Skip to main content
. 2019 Aug 19;14(8):e0220060. doi: 10.1371/journal.pone.0220060

Fig 3. Distribution of EBIs across the evaluation categories (N = 225, n = 118)[28–145].

Fig 3

N represents the total number of EBIs included in this review. n represents the number of publications in which these EBIs are evaluated. ART: antiretroviral therapy; HIV: human immunodeficiency virus.